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Neurotoxicityenovirus-mediated overexpression of NH2-tau fragment lacking the ﬁrst 25
aminoacids evokes a potent neurotoxic effect, sustained by protracted stimulation of NMDA receptors, in
primary neuronal cultures we investigated whether and how chemically synthesized NH2-derived tau
peptides, i.e. NH2-26–44 and NH2-1–25 fragments, affect mitochondrial function. We tested both fragments
on each step of the processes leading to ATP synthesis via oxidative phosphorylation: i) electron ﬂow via the
respiratory chain from physiological substrates to oxygen with the activity of each individual complex of the
respiratory chain investigated in some detail, ii)membrane potential generation arising from externally added
succinate and iii) the activity of both the adenine nucleotide translocator and iv) ATP synthase. Oxidative
phosphorylation is not affected by NH2-1–25 tau fragment, but dramatically impaired by NH2-26–44 tau
fragment. Both cytochrome c oxidase and the adenine nucleotide translocator are targets of NH2-26–44 tau
fragment, but adenine nucleotide translocator is the unique mitochondrial target responsible for impairment
of oxidative phosphorylation by the NH2-26–44 tau fragment, which then exerts deleterious effects on cellular
availability of ATP synthesized into mitochondria.
© 2008 Published by Elsevier B.V.1. Introduction
It is awidely accepted notion that tau protein, which is abundant in
neurons and less common elsewhere, modulates the stability of
microtubules. In Alzheimer's disease (AD), as well as in other human
dementias, tau undergoes a series of post-translational changes
including abnormal phosphorylation, glycosylation, glycation, and
truncation [for refs see [1]], whichmay render tau more prone to form
aggregated structures, the neuroﬁbrillary tangles, which constitute a
major hallmark of AD. Following such aggregation the microtubulesease; ANT, adenine nucleotide
hate; ATP D.S., ATP detecting
-OH,, β-hydroxybutyrate; CGC,
l, trace in the absence of NH2-
ersalyl; NMDA, N-methyl-D-
line medium; RAM, rotenone
trol index; ROT, rotenone; S.D.,
(080) 5443364; fax: +39 080
assarel@unimol.it
lsevier B.V.disintegrate, collapsing the neuron's transport system, with conse-
quent altered communication between neurons and eventually
ending in cell death.
Inappropriate neuronal apoptosis is present in AD, as well as in
other neurodegenerative diseases. Tau is a substrate for the apoptotic
protease(s), i.e. caspase(s) and calpain, in vivo and an effector of
apoptosis itself in vitro in established cell lines [1–4], suggesting that
an incorrect proteolysis may generate one or more tau fragments that
further induce cell death, so contributing to the progression of
neurodegeneration by an “autocatalytic process” [3,4].
With the aim of decoding the functional role of the N-terminal
domain of tau, in distinction to the C-terminal tail which is reported in
the literature to contain the microtubule binding domains [see [5]],
Amadoro et al. [6] overexpressed, using adenovirus-mediated infec-
tion in primary neuronal cultures, some N-derived fragments located
around different protease(s)-cleavage consensus sites in the tau NH2
domain. The authors showed that high intracellular levels of tau N-
terminal fragments lacking the ﬁrst 25 amino acids evoke a potent
neurotoxic effect and induce a necrotic type of cell death, as sustained
by protracted stimulation of N-methyl-D-aspartate (NMDA) extra-
synaptic receptors. The NH2-26–44 tau fragment was the minimal
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1–25 tau fragment was inactive [1,6].
However, the mechanism underlying the NH2-26–44 tau frag-
ment-dependent necrosis remains to be established. Here we
compare NH2-26–44 tau and NH2-1–25 tau fragments with respect
to their effects on mitochondrial function. In particular, we investigate
each step of the processes leading to ATP synthesis via oxidative
phosphorylation: electron ﬂow via the respiratory chain from certain
substrates to oxygen with the activity of each individual complex of
the respiratory chain investigated in some detail, membrane potential
generation and the activity of both the adenine nucleotide translo-
cator (ANT) and ATP synthase (see Scheme 1). Oxidative phosphor-
ylation is not affected by NH2-1–25 tau fragment, but dramatically
impaired by NH2-26–44 fragment. We show that both cytochrome c
oxidase (COX) and the ANTare targets of NH2-26–44 tau fragment, but
ANT is the unique mitochondrial target responsible for impairment of
oxidative phosphorylation.Scheme 1. Effect of NH2-26–44-tau fragment on the oxygen consumption rate under
Uncoupling (A) and ATP synthesis (B) conditions. NH2-26–44-tau fragment has no
effect on the rate of succinate-dependent oxygen consumption stimulated by an
uncoupler (A), in spite of the capability to impair cytochrome c oxidase. Contrarily, in
the presence of ADP (B), inhibition takes place due to NH2-26–44-tau fragment effect
on the Adenine nucleotide translocator (ANT). For details see the text. Main abbre-
viations: DIC, dicarboxylate carrier; FUM, fumarate; Pi, inorganic phosphate; SUCC;
succinate. ⁎ indicate the NH2-26–44-tau fragment targets.2. Materials and methods
2.1. Reagents
Tissue culture medium and fetal calf serum were purchased from
GIBCO (Grand Island, NY) and tissue culture dishes were from NUNC
(Taastrup, Denmark). All enzymes and biochemicals were from Sigma
Chemicals Co. (St Louis, MO, USA). Synthetic peptides: NH2-tau
peptides were synthesized by Sigma Genosys, (Sigma Genosys,
Haverhill, UK) and puriﬁed to N95% homogeneity by reversed-phase
high pressure liquid chromatography on C-18 silica columns with
monitoring of A214 (peptide bonds). Authenticity and purity of
peptides were veriﬁed by MALDI mass spectrometry analysis.
2.2. Cell culture and treatments
Primary cultures of cerebellar granule cells (CGC) were obtained
from dissociated cerebellar of 7-day-old Wistar rats as described by
Levi et al. [7]. Cells were plated in basal medium Eagle (BME,
Invitrogen, Gibco) supplemented with 10% fetal calf serum, 25 mM
KCl, 2 mM glutamine and 100 μg/ml gentamycin on dishes coated with
poly-L-Lysine. Arabinofuranosylcytosine (10 μM) was added to the
culture medium 18–22 h after plating to prevent proliferation of non-
neuronal cells.
2.3. Preparations of cell homogenate and mitochondria
Culture medium was removed and the plated CGC were washed
with phosphate buffer saline medium (PBS), containing 138 mMNaCl,
2.7 mM KCl, 8 mM Na2HPO4, 15 mM KH2PO4, pH 7.4. Cell integrity was
quantitatively assessed by the inability of cells to oxidize externally
added succinate, and by the ability of ouabain to block glucose
transport. Homogenates were prepared from a cell suspension by 10
strokes with a Dounce homogeniser at room temperature. Cytosolic
lactate dehydrogenase was released and subsequent treatment with
Triton X-100 did not cause further release. Mitochondriawere isolated
from cell homogenates [8]. Brieﬂy, the cellular homogenate was
centrifuged at 1500 ×g for 10 min. The pellet was resuspended and
centrifuged at 1500 ×g for 10 min. The combined supernatants were
centrifuged again at 1500 ×g for 10 min. The supernatant obtained
was centrifuged at 17000 ×g for 11 min. The pellet represents the
mitochondrial fraction. All the operations were carried out on ice and
the centrifugations at 4 °C. Puriﬁed mitochondria, incubated in PBS,
were checked both for their coupling efﬁciency by measuring the
respiratory control index, i.e. (oxygen uptake rate after ADP addition)/
(oxygen uptake rate before ADP addition), which reﬂects the ability of
mitochondria to produce ATP, and for their intactness bymeasuring in
the post-mitochondrial supernatant the activities of adenylate kinase
(ADK, E.C.2.7.4.3) and glutamate dehydrogenase (GDH, E.C.1.4.1.3),
which are marker enzymes of the mitochondrial intermembrane
space and matrix, respectively. Protein content was determined
according to Waddel and Hill [9] with bovine serum albumin used
as a standard.
2.4. Polarographic measurements
O2 consumption was measured polarographically by means of a
Gilson 5/6 oxygraph using a Clark electrode [10]. The cell homogenate
in PBS (about 0.2 mg protein) was incubated in a thermostated (25 °C)
water-jacketed glass vessel (ﬁnal volume equal to 1.5 ml), and
polarographic measurements were performed as substrate-inhibitor
analyses in the presence of 1 mM ADP or 0.12 μM FCCP. The following
substrates and inhibitors were used: 5 mM β-hydroxybutyrate (β-
OH), 3 μM rotenone (ROT), 5 mM succinate (SUCC), 0.8 μM antimycin
A (AA). Instrument sensitivity was such as to allow rates of O2 uptake
as low as 0.5 natom min−1 mg−1 protein to be followed.
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complexes I–IV
Enzymatic activities were assayed photometrically at 25 °C. Each
assay was performed at least in duplicate with two different volumes
of CGC (0.2 mg protein) solubilised with 0.5% Triton X-100 and
incubated in 2.5ml of amedium containing Phosphate-Tris 50mMand
EDTA 2 mM. Complex I+ III and Complex II+ III were measured at 548–
540 nm by following the reduction of ferricytochrome c (10–50 μM)
after the addition of 0.5 mM NADH or 10 mM succinate, respectively.
The extinction coefﬁcient for cytochrome c is 21.1 μM−1 cm−1 [for refs
see [11]]. Complex IV, i.e. cytochrome c oxidase, was measured by
recording the decrease in absorbance during the cyanide-sensitive
oxidation of 40 μMferrocytochrome c (reducedwith substoichiometric
concentrations of potassium ascorbate) at 548–540 nm [12]. Time-
dependent absorbance changes were recorded with a Jasco double-
beam/double-wavelength spectrophotometer UV-550. The rates of
ferricytochrome c reduction or ferrocytochrome c oxidation were
obtained as tangents to the initial parts of the progress curves.
2.6. Safranine O response assay
The safranine O response was monitored as in Atlante et al. [13].
Time-dependent absorbance changes were recorded with a Jasco
double-beam/double-wavelength spectrophotometer UV-550 with
wavelengths of 520–554 nm. Measurements were carried out at
25 °C in 2 ml of standard medium consisting of 200 mM sucrose,Fig.1. Effect of NH2-tau fragments onmitochondrial oxygen consumption (state 4) by CGC hom
CGC homogenates (0.2 mg cell protein) were incubated at 25 °C in a water-jacketed glass ves
5 mM), succinate (SUCC, 5 mM), rotenone (ROT, 3 μM) and antimycin A (AA, 0.8 μM) were
fragments. NH2-tau fragments (1–25 and 26–44, each 1 μM) were added 2 min before the add
min mg cell protein. In the table the means+S.D. of the oxygen consumption rates are rep
preparations. ANOVA and Bonferroni test: No statistically signiﬁcantly differences when pN10 mM KCl, 1 mMMgCl2, 20 mM HEPES–Tris, pH 7.2, containing 1 mM
safranine O and 0.1 mg protein.
2.7. ADP/ATP carrier measurements
Cell homogenates (0.1 mg protein), containing mitochondria, were
incubated at 25 °C in 2 ml of standard medium consisting of 200 mM
sucrose, 10 mM KCl, 1 mM MgCl2, and 20 mM HEPES–Tris pH 7.2. The
appearance of ATP in the extramitochondrial phase, due to externally
added ADP, was assayed, as in Atlante et al. [10], by using the ATP
detecting system (ATP D.S.) consisting of glucose (2.5 mM), hexoki-
nase (HK, 0.5 e.u.), glucose-6-phosphate dehydrogenase (G-6-PDH,
0.5 e.u.) and NADP+ (0.2mM) in the presence of P1,P5-Di(adenosine-5′)
penta-phosphate (Ap5A), a speciﬁc inhibitor of adenylate kinase. The
rate of NADP+ reduction in the extramitochondrial phase was
determined following the absorbance increase at 334 nm, measured
as the tangent to the initial part of the progress curve and expressed as
nmol NADP+ reduced/min mg cell protein. Control experiments were
carried out in the presence of atractyloside (ATR) to ensure that the
ADP/ATP exchange was mediated exclusively by the ANT [10].
2.8. Measurement of ATPase activity
ATPase activity was assayed, as reported in [14], by measuring
mitochondrial swelling, which occurred when ATP hydrolysis was
elicited in mersalyl-treated mitochondria incubated with ATP. One
minute after addition of mersalyl (20 nmol mg−1 protein) to theogenates due to physiological respiratory substrates, β-hydroxybutyrate and succinate.
sel and consumption of O2 was monitored polarographically. β-hydroxybutyrate (β-OH,
added at the indicated times. Control indicates the traces in the absence of NH2-tau
ition of the respiratory substrates. Rates of oxygen uptake were expressed as natom O2/
orted. The S.D. was obtained from ﬁve experiments, carried out by using different cell
0.05.
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hydrolysis was induced by adding 0.12 μM FCCP.
2.9. Statistical analysis
Experiments were carried out in triplicates and repeated at least
three times. Data were expressed as means±Standard Deviation (S.D.)
(n=3). Statistical signiﬁcance of the data was evaluated using the one-
way analysis of variance (ANOVA) followed by post-hoc Bonferroni
test. pb0.05 was considered as signiﬁcant for all analyses.
3. Results
To ascertain whether and how NH2-1–25 and NH2-26–44 tau
fragments affect mitochondrial oxidative phosphorylation in CGC
homogenate, we examined separately all the steps leading to ATP
synthesis and export from the mitochondria. These are: a) Respiratory
substrate transport across the inner mitochondrial membrane; b)
Substrate oxidation by speciﬁc dehydrogenases; c) electron ﬂow along
the respiratory chain; d) ΔμH+ generation; e) ADP/ATP exchangeFig. 2. Effect of NH2-tau fragments on respiratory chain complex activities. CGC were collecte
were assayed as reported in the Materials and methods section. (a) Complex I+ III: 0.1 mg pro
2mM EDTA and 2mg/ml BSA, in the presence of 50 μM ferricytochrome c, 1 mMKCN and 0.1%
Complex II+ III: 0.2 mg protein of CGC were incubated at 25 °C in 2.5 ml of standard mediu
rotenone. At the times indicated by the arrows, the following were added: 10 mM succinate (
to a spectrophotometric cuvette containing in 2.5 ml 3 μM rotenone and 0.8 μM antimycin A
protein of CGC, and blocked with 1 mM cyanide (CN−). Numbers along the traces give th
respectively) and ferrocytochrome c oxidation, (trace c)), measured as tangent to the initial p
the means+S.D. of the respiratory complex activities in the absence or presence of NH2-t
experiments, carried out by using different cell preparations from different groups of anim
signiﬁcantly differences when pN0.05; Statistically signiﬁcantly differences when pb0.001.across the inner mitochondrial membrane via ANT; f) ΔμH+ driven ATP
synthesis by ATP synthase.
Since oxidative phosphorylation occurs only in intact mitochon-
dria, we used either cell homogenate containing mitochondria or
isolated mitochondria for these experiments, as in [10]. In either case
mitochondrial coupling was previously checked.
3.1. Effect of NH2-tau fragments on oxygen consumption by CGC homogenate
First oxygen consumption by CGC homogenate was monitored in
State 4, i.e. in the absence of either ADP or uncoupler, arising from
different substrates whose oxidation is physiologically linked to
Complex I (β-hydroxybutyrate) and Complex II (succinate).
In a typical experiment (Fig. 1), neither NH2-1–25 nor NH2-26–44
tau fragments had any signiﬁcant effect on oxygen consumption rate,
with respect to the control (v=8 natomO2/min/mg cell protein), in the
case of rotenone-sensitive oxidation of β-hydroxybutyrate (β-OH,
5 mM) (v=9 and 8 natom O2/min/mg cell protein, respectively) (Fig. 1)
or on mitochondrial respiration due to externally added succinate
(SUCC, 5 mM) (v=18, 20 and 19 natom O2/min/mg cell protein in thed and solubilised (seeMaterials andmethods section). Then respiratory chain complexes
tein of CGC were incubated at 25 °C in 2.5 ml of standard medium, containing 10 mM Pi,
potassium deoxycholate. Further additions: 0.5 mMNADH and 3 μM rotenone (ROT). (b)
m in the presence of 10 μM ferricytochrome c, 0.1% potassium deoxycholate and 3 μM
SUCC) and 0.8 μMAntimycin A (AA). (c) Complex IV: 40 μM ferrocytochrome cwas added
and the absorbance was recorded. The reaction was started with the addition of 7.5 μg
e rate of ferricytochrome c reduction by either NADH or succinate (traces a and b),
art of the progress curve and expressed as nmoles min−1 mg−1 cell protein. In the table
au fragments (1–25 and 26–44, each 1 μM) are reported. S.D. was obtained from six
als and the variations ranged within 10%. ANOVA and Bonferroni test: No statistically
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fragments, respectively) (Fig. 1).
A statistical analysis according to ANOVA followed by the
Bonferroni test (ﬁve experiments carried out with 5 different cell
homogenates) (see Table to Fig. 1) conﬁrms that addition of the NH2-
1–25 fragment treatment did not change the rate of oxygen uptake
with any of the substrates investigated (pN0.05).
The results in Fig. 1 do not show unambiguously that tau fragments
are without effect on oxygen uptake by complexes I and II because
oxygen uptake requires transport of the externally added substrate
(either via diffusion in the case of β-hydroxybutyrate or in a carrier
mediatedmanner in the case of succinate), and so the possibility arises
that the transport step is rate limiting. This would mask any possible
effects of the tau fragments. To rule out this possibility, a parallel
experiment was carried out in which the activities of the respiratory
chain complexes, i.e. Complex I-III: NADH-ferricytochrome c oxidor-
eductase and Complex II–III: Succinic:ferricytochrome c oxidoreduc-
tase were assayed. Moreover Complex IVwas also monitored. This was
made photometrically (for details see theMaterials andmethods)with
the results shown in Fig. 2. The NH2-1–25 tau fragment was without
effect on the respiratory complex activities in all cases. On the other
hand the presence of NH2-26–44 tau fragment led to about 50% of
inhibition of the activity of Complex IV, monitored as cyanide-sensitiveFig. 3. Effect of NH2-tau fragments on generation of mitochondrial membrane potential. Mit
containing safranine O (1 μM). Arrows denote the following additions: succinate (SUCC, 5
succinate addition at a ﬁnal concentration of 1 μM. Control indicates the trace in the absence o
addition of the substrate. The safranine O response was monitored at 520 nm as described i
extent values (±S.D.), in the absence or presence of NH2-tau fragments (1–25 and 26–44, each
addition)− (A520 value after Δψ generation due to succinate addition) respectively, are repooxidation of reduced cytochrome c (Fig. 2c and Table, line 3), as in [12].
No effect of NH2-26–44 tau fragment was found when either 0.5 mM
NADH (used to measure Complex I+ III) or 10 mM succinate (used to
measure Complex II+ III) were added to solubilised CGC to reduce the
added ferricytochrome c (50 μM) (Table 1, lines 1 and 2). In the same
experimentwe conﬁrmed that these reactionswere almost completely
inhibited by rotenone and antimycin, respectively (see Fig. 2a and b).
3.2. Effect of NH2-tau fragments on generation of mitochondrial
membrane potential in isolated CGC mitochondria
Isolated mitochondria were supplemented with succinate
(5 mM), the only respiratory substrate which donates reducing
equivalents directly to the respiratory chain, and the generation of
membrane potential (Δψ) was monitored by the decrease of
safranine O absorbance at 520 nm (Fig. 3). Neither the rate nor the
extent of Δψ generation was signiﬁcantly affected by the addition of
NH2-tau fragments (pN0.05). Generation of Δψ was completely
prevented by antimycin A (AA, 0.8 μM), an inhibitor of Complex III of
the respiratory chain, and, as expected, the membrane potential was
abolished by FCCP (0.12 μM). It should also be noted that the NH2-1–
25 and NH2-26–44 tau fragments neither generate Δψ nor abolish
endogenous Δψ.ochondria (0.1 mg protein) isolated from CGC were suspended at 25 °C in 1.5 ml of PBS
mM), FCCP (0.12 μM). NH2-tau fragments (1–25 and 26–44) were added 2 min before
f NH2-tau fragments. Where indicated antymicin A (AA, 0.2 μg) was added 2min before
n the Materials and methods section. In the table, both the Δψ generation rate and the
1 μM), expressed as ΔA520/min mg cell protein and ΔA520=(A520 value before succinate
rted.
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Having ascertained that neither of the NH2-tau fragments has any
effect on Complex I and II-dependent oxygen uptake and that they do
not abolish the mitochondrial membrane potential, we investigated
their effect on Uncoupled/State 3 respiration inwhich oxygen uptake is
stimulated either by using an uncoupler or by addition of ADP,
respectively. The difference is that in the former case the stimulation
of oxygen uptake derives from collapse of the electrochemical proton
gradient without ATP synthesis, whereas in the latter case ADP is used
to drive ATP synthesis.
In the ﬁrst set of experiments, the uncoupler FCCP was used to
stimulate succinate oxidation. Mitochondria from cell homogenate in
State 4, i.e. in the presence of the succinate alone, took up oxygen at a
rate of 19 natom O2/min mg cell protein. The addition of FCCP
increased the rate of oxygen uptake up to 116 natom O2/min mg cell
protein (Fig 4a) with an Uncoupling Control Ratio (the ratio of the rate
of oxygen uptake in uncoupled respiration and State 4) equal to 6. No
change in the rate of oxygen uptake occurred when NH2-tau
fragments were added separately either before (Fig. 4a’–a”) or after
the respiratory substrate (Fig. 4b’–b”), further conﬁrming that the
electron ﬂow along the respiratory chain is not affected by either
fragment. These data also conﬁrmed that neither of the NH2-tau
fragments functions as an uncoupler.
On the other hand, when ADP was used to stimulate the oxygen
uptake arising from externally added succinate (Fig. 4b), the rate of
oxygen uptake increased (to 67 natom O2/min mg cell protein) with
RCI value equal to 3.5. In the presence of the NH2-26–44 tau
fragment (1 μM), added either before (Fig. 4c’) or after ADP (Fig. 4d’),
the rate enhancement due to ADP phosphorylation was essentiallyFig. 4. Effect of NH2-tau fragments on mitochondrial oxygen consumption (state 3) by CGC
protein) were incubated at 25 °C in a water-jacketed glass vessel and consumption of O2 was
NH2-tau fragments (1–25 and 26–44, each 1 μM) were added at the indicated times. Control
(RCI), i.e. oxygen uptake rate after FCCP/ADP addition/oxygen uptake rate before FCCP/ADP a
electrochemical proton gradient or to produce ATP. Rates of oxygen uptake were expressedabolished. The NH2-1–25 tau fragment (1 μM) was without effect
(Fig. 4c”–d”).
Given that generation of ΔμH+ is not affected by either NH2-tau
fragment (see Fig. 3), it was necessary to examine other possible
causes for the NH2-26–44 fragment-dependent inhibition of ADP-
stimulated oxygen uptake. To this end, we investigated both ADP/ATP
exchange via ANT and ATP synthase activity [see [10]].
In the case of ANT, we resorted to a procedure that allows for the
continuous monitoring of ATP efﬂux from CGC homogenate incubated
with ADP [10]. In a typical experiment, the homogenates, treated with
AP5A to inhibit adenylate kinase and thus preventing mitochondrial
ATP synthesis in a manner not dependent on oxidative phosphoryla-
tion [see also [10]], were incubated in the presence of an ATP detecting
system (ATP D.S.) (see Materials and methods section). The ATP
concentration in the extramitochondrial phase of the homogenates
was negligible as shown by the fact that no increase in the absorbance
measured at 334 nmwas found in the presence of glucose, hexokinase,
glucose-6-phosphate dehydrogenase and NADP+. As a result of
addition of ADP (0.04 mM), an increase in the NADPH absorbance
was observed indicating the appearance of ATP in the extramitochon-
drial phase (Fig. 5A). As shown in Fig. 5B, NADPH formation derives
from i) ADP uptake into mitochondria in exchange for endogenous
ATP, ii) ATP synthesis from imported ADP via ATP synthase and iii)
efﬂux of the newly synthesized ATP from the mitochondria in
exchange for further ADP via ANT (it should be noted that, under
the reported experimental conditions, the energy for ATP synthesis is
apparently given by the oxidation of endogenous substrates).
As expected, NADPH formation was completely inhibited by the
presence of oligomycin (OLIGO, 10 μM), an inhibitor of ATP synthase,
further conﬁrming that no ATP could be synthesized via substrate-levelhomogenates due to succinate plus either FCCP or ADP. CGC homogenates (0.2 mg cell
monitored polarographically. Succinate (SUCC, 5 mM), FCCP (0.12 μM), ADP (1 mM) and
indicates the traces in the absence of NH2-tau fragments. The respiratory control index
ddition, reﬂects the ability of mitochondria either to respond to the abolishment of the
as natom O2/min mg cell protein.
Fig. 5. Effect of NH2-tau fragments on the ADP/ATP exchange via ANT in CGC. Appearance of ATP due to ADP addition to CGC homogenates (0.1 mg protein) was monitored as
described in the Materials and methods. NH2-tau fragments (1–25 and 26–44) were added, 2 min before ADP, at a ﬁnal concentration of 1 μM. Control depicts the traces in the
absence of NH2-tau fragments.( A) Atractyloside (ATR, 10 μM), oligomycin (OLIGO, 10 μM), β-OH-butyrate (5 mM) and a cocktail of respiratory chain inhibitors, i.e. rotenone (3 μM ),
antimycin A (0.8 μM) and mixothiazole (6 μM) (RAM) plus cyanide (CN−, 1 mM), were added to the reaction mixtures. ADP concentration was equal to 0.04 mM. (B) Scheme
representing the ATP Detecting System. For details see the text. Main abbreviations: Ap5A, P1,P5-di(adenosine-5′)penta-phosphate; ANT, adenine nucleotide translocator; ATR,
atractyloside; HK, hexokinase; G6PDH, glucose-6-Pi dehydrogenase; OLIGO, oligomycin; IMS, inner mitochondrial space; MIM, mitochondrial inner membrane; MOM,mitochondrial
outer membrane. (C and D) Appearance of ATP due to ADP (0.5 mM) addition to CGC homogenates in the absence (Control) or presence of either NH2-1–25 (C) or NH2-26–44-tau
fragment (D) (1 μM each). (E and F) The plot of 1/absorbance increase rate against NH2-26–44 tau fragment concentration and the plot of 1/i against 1/[inhibitor], where i=1−vi/vo; vi
and vo are the rates of ADP/ATP exchange in the presence and in the absence of inhibitor, i.e. either atractyloside (ATR, ○) or NH2-26–44 tau fragment (▲), respectively, are reported.
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atractyloside (ATR, 10 μM), an ANT inhibitor, strongly inhibited
NADPH formation (Fig. 5Aa), as expected in light of the Ki value
(about 3 μM) [see [10]] and of the ADP and atractyloside concentrationsused. In a parallel experiment, to ascertain that mitochondria
themselves can drive ATP synthesis without any limitation due to
energy deﬁcit, we energized cell homogenates by adding β-OH (5 mM),
thus increasing membrane potential (Fig. 5Ab). Since the rate of ATP
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concluded that the mitochondria themselves can generate the electro-
chemical proton gradient needed for ATP synthesis. Conversely,
prevention of ΔμH+ formation from endogenous substrates by the
addition of a cocktail of the electron ﬂow inhibitors rotenone, antimycin
A, mixothiazole (RAM) and cyanide (CN−) resulted in blocking of ATP
production (Fig. 5Ab).
The rate of NADPH formation found in these experiments was
approximately 14 nmol NADP+ reduced/min mg cell protein, in good
agreement with values obtained by Atlante et al. [10]. When NH2-26–
44 tau was added, this rate was strongly decreased to 1.5 and 2 nmol
NADP+ reduced/min mg cell protein with the fragment added either
before (Fig. 5Ca) or after ADP (Fig. 5Cb) respectively. NH2-1–25 tau
fragment was without effect (Fig. 5Da, b).
Since ANT activity measured in mitochondria could depend on a
number of events including electron ﬂow across the mitochondrial
membrane, electrochemical proton gradient generation, ATP synthase
activity and the adenine nucleotide content of the mitochondria, we
investigated the rate limiting step of the process leading to ATP efﬂux
from the mitochondria.
That the rate of NADPH formation mirrored the rate of ADP/ATP
exchange was veriﬁed by measuring the rate of ATP appearance, due
to externally added ADP, in the absence or presence of increasing
concentrations of either atractyloside or NH2-26–44 tau fragment (Fig.
5E, F). Data obtained have been plotted both as a Dixon plot and as 1/i
against 1/[Inhibitor], where the fractional inhibition i=1−vi/vo (vi and
vo were the rates of ATP efﬂux in the presence or absence of the
inhibitor, respectively). In the former case the intercepts of the line
obtained by ﬁtting the experimental points obtained in the presence
of either NH2-26–44 tau fragment (Fig. 5E) or atractyloside (not
shown) coincide with that obtained in the absence of inhibitor. This
allows the conclusion that ANT itself is the target of NH2-26–44 tau
fragment. Ki is about 0.5 μM. In the latter case, the intercept on the y-
axis was 1 showing that atractyloside, as well as NH2-26–44 tau
fragment, completely prevented ADP/ATP exchange (Fig. 5F).
The conclusion that neither the electron ﬂow across the mitochon-
drial membrane, nor the electrochemical proton gradient, nor the ATP
synthase (see below) limited the rate of NADPH formation is also
suggested by the observation that NH2-26–44 did not impair the
electron ﬂow along the respiratory chain, Δψ generation (see above),
or also ATP synthase activity (see below). This conclusion is also
conﬁrmed by the ﬁnding that the coupled enzymatic system used to
detect ATP outside mitochondria was not rate limiting per se by
showing that addition of 5 μMATP resulted in an increase of the rate of
change of absorbance, whereas no rate increase occurred when the
concentrations of either the substrate or enzyme components of the
ATP D.S. were increased. Taken together, these studies indicate that
the major action of the NH2-26–44 tau fragment on mitochondrial
oxidative phosphorylation is at the level only of the ANT.
3.4. Effect of NH2-tau fragments on mitochondrial ATP synthase
The sensitivity of mitochondrial ATPase to NH2-tau fragments was
investigated by checking whether these fragments could prevent the
FCCP-stimulated swelling of mersalyl-treated mitochondria incubated
with 2 mM ATP. This swelling has been reported to occur when
phosphate and ADP formation (caused by ATP hydrolysis via ATPase
stimulated by FCCP) takes place in the matrix of mitochondria in
which the phosphate carrier is inhibited by mersalyl [see [14]]. As
expected, mitochondrial swelling was strongly inhibited in the pre-
sence of oligomycin (OLIGO, 10 μM), which inhibits ATP synthase (Fig.
6Aa), as well as partially inhibited in the presence of atractyloside
(ATR, 10 μM) (Fig. 6Ab). As a control, it was veriﬁed that no swelling
occurred whenmersalyl was absent (Fig. 6Ac). No change in the rate of
mitochondrial swelling, with respect to the control, was found when
either NH2-1–25 or NH2-26–44 tau fragment was added after ATPaddition and accumulation into mitochondria (Fig. 6Ba, Ca), thus
showing that there was no inhibition of mitochondrial ATPase.
Nonetheless mitochondria showed swelling with a rate and to an
extent lower than that found in controls (Fig. 6Cb) when they were
previously incubated with NH2-26–44 tau fragment, but not with
NH2-1–25 fragment (Fig. 6Bb). This ﬁnding suggests that the observed
impairment is likely due to the effect of NH2-26–44 tau fragment on
ATP accumulation into mitochondria. On the other hand, these data
besides demonstrating that both NH2-tau fragments tested were
ineffective on ATP synthase, conﬁrm the inhibitory effect of NH2-26–
44 tau fragment on ANT, and suggest that the inhibition is likely non-
competitive.
4. Discussion
We show here that externally added NH2-26–44 tau fragment can
impair oxidative phosphorylation as investigated in vitro with CGC
homogenates containing intact coupled mitochondria and that this
occurs due to the impairment of themitochondrial ANT (Figs. 4 and 5).
Such an impairment could account for the reduced availability of ATP
already proposed as the cause of the excitotoxic NMDAR activity-
mediated death in Alzheimer disease. In this case the reduced ATP
availability in the cytosol could in turn cause glutamate release from
the cell and then excitotoxicity [1,6] (see Scheme 2).
The conclusion that NH2-26–44 tau fragment inhibits ADP/ATP
exchange as measured in intact coupled mitochondria rests on the
conﬁrmation, as in [10], that the increase of the measured absorbance
reﬂects the rate of ANT mediated ADP/ATP exchange. This is shown by
the experiment in which the reciprocal of absorbance increase rate
was plotted as a function of either NH2-26–44 tau fragment (Fig. 5E) or
atractyloside concentration (not shown). In both cases the intercepts
of the line obtained by ﬁtting the experimental points obtained in the
presence of NH2-26–44 tau fragment or of atractyloside coincide with
that obtained in the absence of inhibitor.
The implication of this is that ANT itself is the target of NH2-26–44
tau fragment. Consistently we conﬁrmed that the decrease in ANT
activity does not depend on the failure of mitochondria to generate
membrane potential, which is used as driving force for ATP efﬂux, by
showing that the addition to mitochondria of β-hydroxybutyrate, a
respiratory substrate which enters mitochondria via diffusion with an
increase in membrane potential, is not accompanied by stimulation of
ANT transport activity (Fig. 5Ab). Consistently, we have found that the
activity of the ATP synthase, assayed as in [14], was not affected by
NH2-26–44 tau fragment (Fig. 6). Interestingly, since inhibition of
ATPase-dependent swelling is found only when NH2-26–44 tau
fragment was added before ATP used at 2 mM concentration and
was not removed by subsequent addition of ATP at up to 10 mM (not
shown) we might suggest that the inhibition is non-competitive. It
should be noted that in late apoptosis a non-competitive-like
inhibition of ANT was found, probably due to caspase(s) activity
[10], but not dependent on a direct caspase–ANT interaction. However
since NH2-26–44 tau fragment is likely to be generated during
apoptosis given that the N-terminal domain of tau contains consensus
sequences suitable for cleavage by caspase(s) [2,15], which are
activated in apoptotic degenerating neurons in AD [16–20], the
possibility exists that caspase(s) gradually inhibit/s ANT as a result of
NH2-tau cleavage and generation of toxic NH2-26–44 tau fragment. In
this case NH2-26–44 tau fragment should bind ANT.
Possible effects of tau fragments on other steps of the process
leading to ATP synthesis, via oxidative phosphorylation, in energized
mitochondria have been investigated by measuring State 3 and 4
respiration: NH2-tau fragments failed to impair the electron ﬂow in the
mitochondrial respiratory chain (Figs. 1, 2), ΔμH+ generation (Fig. 3) and
ΔμH+-driven ATP synthase (Fig. 6). These conclusions are not unique:
Cardoso et al. [21] found no differences in NADH-ubiquinone
oxidoreductase (Complex I) or succinate dehydrogenase-cytochrome c
Fig. 6. Effect of NH2-tau fragments on mitochondrial ATP synthase in CGC. ATP hydrolysis, induced by externally added FCCP to mersalyl-treated-mitochondria (0.2 mg protein), was
followed as reported in the Materials and methods. Arrows indicate where additions were made: 2 mM ATP, 0.12 μM FCCP, 1 μM NH2-1–25 or-26–44 tau fragment. Control indicates
the traces in the absence of NH2-tau fragments. Oligomycin (OLIGO, 2 μM) and atractyloside (ATR, 10 μM) (in A,a and b) were added 2 min before ATP addition; No-MERS (in A,c)
indicates that mersalyl (20 nmol/mgmitochondrial protein) is not present in themitochondrial suspension. NH2-tau fragments (1–25 or 26–44) were added where indicated (B,a and
C,a) and 2 min before ATP addition (in B,b and C,b). Absorbance changes at 546 nm were continuously recorded with a Perkin-Elmer Lambda 5 spectrophotometer.
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AD platelets in which the ATP levels proved to decrease and control
mitochondria. In another paperMancuso et al. [22] showed no decrease
in activity of F1F0-ATPase in hippocampus and platelets of AD cases.
Our results also call into question some previous observations
about the possible role of cytochrome oxidase in AD. It was
proposed that a decrease in COX activity and/or in the levels of
COX polypeptides, responsible for mitochondrial dysfunction, may
be the fundamental cause of AD [23–26]. However, we showthat the inhibition of COX activity by NH2-26–44 fragment is of
secondary importance since COX is not limiting the electron ﬂow
along the respiratory chain due to both β-OH and succinate (Fig. 1).
The COX activity assay, measured as an isolated step of the res-
piratory chain, as well as the failure to impair oxygen uptake when
either β-hydroxybutyrate or succinate was used as respiratory
substrate, strongly suggests that COX capacity exceeds that required
to support respiration, i.e. COX is not the limiting step in oxygen
uptake.
Scheme 2. (A) Normal conditions: i) Mitochondria produce ATP; ii) Na+/K+ pump utilizes cell ATP to transport Na+ and K+ across plasma membrane thus maintaining membrane
potential; iii) Extracellular glutamate level is kept below toxic level by its reuptake through high-afﬁnity Na+-dependent excitatory amino acid transporter (EAAT) [63]. (B)TAU
fragment production conditions : i) Tau fragment affects mitochondrial ATP production, ii) the transmembrane gradients of Na+ collapse due to a reversal of the Na+/K+ pump; iii)
electrogenic Na+-coupled transporter (EAAT) reverses, then releasing glutamate into the extracellular space; iv) high extracellular glutamate level causes excitotoxic neuronal death,
which involves activation of ionotropic glutamate receptors and excessive calcium inﬂux in neurons [64] and induce excitotoxic death. Main abbreviations: EAAT, excitatory amino
acid transporter; GLU, glutamate.
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rate of respiration in the absence of ADP in neocortical homogenate
derived from Alzheimer's patients was found, we show that NH2-tau
fragments do not cause mitochondrial uncoupling (Fig. 4). We suggest
these effects could derive from the action of compounds accumulated
in cells during AD, for instance oxidized lipids leading to mitochon-
drial uncoupling.Since the same fragment does not impair FCCP-stimulated oxygen
consumption, but only ADP-stimulated oxygen consumption (Fig. 4),
we can exclude the steps which are shared by the two processes (see
Scheme 1) as being responsible for the impairment of ATP production.
Notice that if the dicarboxylate carrier or the succinate dehydrogenase
were sensitive to NH2-26–44 tau fragment, thus becoming the rate
limiting step of the process leading to oxygen uptake, its rate in the
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would remain the same. This is not the case.
The experimental approach used to address the role of NH2-26–44
fragment in CGC energy metabolism merits some discussion. Since
mitochondrial ATP synthesis and efﬂux outside mitochondria is a
multistep process requiring intact coupled mitochondria and occur-
ring in a manner regulated by the rate of the limiting step, any study
dealing with isolated enzyme/proteins or with artiﬁcial systems is
of limited use. Thus we have used CGC homogenates to study the
different steps resulting in the availability of ATP outside mitochon-
dria both in their entirety and as partial or individual processes. In the
ﬁrst case we have found that ATP appearance outside mitochondria
caused by ADP addition decreases in the presence of NH2-26–44 tau
fragment. In agreement with [28], this fragment was used in 0.5–1 μM
range: under physiological conditions, the tau concentration in a
neurons is about 2 μM [28,29] and essentially all of the tau protein
(N95%) is tightly bound to microtubules. However, under pathological
conditions, as in the case of tau truncation, modiﬁed tau detaches
from microtubules and accumulates in free form at least up to 0.5–
1 μM. The mechanism by which NH2-26–44 tau fragment impairs ANT
are at present a matter of speculation. Since Yang et al. [30] showed
that as a consequence of glycation, PHF-tau from AD and AGE-tau
generate oxygen free radicals and since Cente et al. [31] reported that
expression of a human truncated variant form of tau protein leads to
the accumulation of ROS, the possibility that ANT impairment derived
from ROS–protein interaction has been considered. However, in a
control experiment, not reported here, we have found that in our
model system no ROS production occurs under condition in which
ANT (itself a target of ROS [10]) is impaired.
The possibility that ANT impairment derives from protein–
protein interaction should be carefully considered. Several studies
exist in which different aspects of putative interaction sites, such as
hydrophobicity, residue propensities, size, shape, solvent accessi-
bility, and residue pairing preferences, are examined [32–43].
Although each of these parameters provides some information
indicative of protein interaction sites, none of them perfectly dif-
ferentiates interaction sites from the rest of the protein surfaces. As
far as the interaction of tau peptides and ANT is concerned, a simple
comparison of the peptides and the ANT isoform sequences, based
on the six-transmembrane model (three-repeat domain structure)
proposed by Klingenberg [44], does not reveal any element which
could be predictive of a direct interaction such as cysteine [45] or
proline [46] residues. Nonetheless it must also be considered that
since NH2-26–44 tau fragment is a non-competitive inhibitor, it does
not interact with the catalytic but with some other site of the
enzyme which could distort the enzyme's structure thus effecting
also the catalytic binding site. In particular, to characterize the me-
chanism(s) regulating ANT function may be important not only in
the elucidation of pathways contributing to necrosis but also in
understanding the pathogenesis of various taupathies which may
result from the altered function of ANT. We intend therefore to
investigate the tau peptide-ANT interaction further by using speciﬁc
antibodies against the two proteins and a co-immunoprecipitation
approach which can be considered as one of the most useful tech-
niques for revealing protein–protein interactions.
The data reported here conﬁrm a clear association between mi-
tochondrial dysfunction and neuronal damage/death in the physio-
pathology of Alzheimer's disease characterized by the altered function
and/or structure of tau protein. Previous studies have demonstrated
enhanced susceptibility to oxidative insults caused by mitochondrial
dysfunction following overexpression of wild-type or mutant [47-51],
or truncated variants of human tau protein [31,52]. Our results
indicate that it is a short NH2-tau fragment that impairs mitochondrial
function, providing a possible cellular link between NH2-tau trunca-
tion, mitochondrial dysfunction and excitotoxic neuronal death.
Therefore, it is tempting to speculate that whenever an improperapoptotic event is triggered in certain neuronal populations, NH2-
derived tau fragment is generated and binds directly to mitochondria,
thus inhibiting their functions similarly to the deleterious effect of
SOD 1 (superoxide dismutase 1) in amyotrophic lateral sclerosis
[53,54] and of mutant Htt (polyQ expanded-Huntington) in Hung-
tington disease [55–57]. In addition, it has been reported that mic-
rotubules and microtubule-associated proteins (MAPs) intracellularly
interact with rat brain mitochondria [58] and that β-amyloid binds
in vivo with ABAD (Abeta-binding alcohol dehydrogenase) in the
mitochondria of AD patients and transgenic mice [59]. Probably at the
level of mitochondria, both Alzheimer proteins, i.e. β-amyloid and tau
proteins, exhibit synergistic effects ﬁnally leading to accelerating
neurodegenerative mechanisms.
Moreover it has been shown that en route to apoptosis, alteration
of the ANT occurs resulting in opening of the permeability transition
pore, this depending on caspase(s) action on pore component/s other
than ADP/ATP translocator [10]. Our results might suggest the
possibility that in apoptosis caspase(s) cause/s also tau truncation
[6] ﬁnally inducing a further ANT impairment.
All together the results reported here and in [1,6] prove that
caspase(s) play/s a dual pivotal role in apoptosis not only by
degradation of endogenous tau thereby reducing the intracellular
endogenous pool of full length tau available for binding to micro-
tubules, but also by generating the production of the neurotoxic NH2-
26–44 tau fragment that impairs the mitochondrial ANT and then ATP
cellular availability.
The picture emerging from this and previous papers to account for
AD progression is that caspase(s) activity in the late phase of neuron
apoptosis leads to tau truncation producing the toxic tau fragment
[60,61]. This results in neurodegeneration arising from glutamate
excitotoxicity in the surrounding tissue [62] (see Scheme 2). This is in
contrast with the conclusions of Chung et al. [4] who proposed a pro-
apoptotic effect of tau cleavage product generated by caspase-3. The
knowledge that mitochondrial dysfunction, with a key role played by
ANT impairment, is of central importance in Alzheimer's disease
opens a window for new therapeutic strategies aimed to preserve/
ameliorate mitochondrial function, and represents an exciting
challenge for biochemists.
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